悦心健康(002162) - 2015 Q1 - 季度财报

Financial Performance - Revenue for Q1 2015 was CNY 105,749,336.53, a decrease of 32.64% compared to CNY 156,998,334.02 in the same period last year[8] - Net profit attributable to shareholders was a loss of CNY 21,509,800.87, representing a 4.59% increase in loss from CNY 20,565,623.79 year-on-year[8] - Operating revenue for Q1 2015 was ¥105,749,336.53, a decrease of ¥51,248,997.49 or 32.64% compared to Q1 2014[19] - Operating profit for Q1 2015 was -¥22,641,887.68, a decrease of ¥5,258,563.69 or 30.25% compared to the previous year[19] - The company reported a significant increase in non-operating income, which rose to ¥1,587,283.99, an increase of 2705.32% year-on-year[19] - The net profit attributable to shareholders for the first half of 2015 is expected to range from 0 to 10 million yuan, with a year-on-year change of -100.00% to 145.00%[29] - The net profit for the first half of 2014 was 4.0825 million yuan, indicating that the company's performance is expected to remain stable compared to the previous year[29] Cash Flow and Assets - Net cash flow from operating activities decreased by 51.32% to CNY 13,230,660.84 from CNY 27,180,147.37 in the previous year[8] - Net cash flow from operating activities was ¥13,230,660.84, a decrease of ¥13,949,486.53 or 51.32% compared to the same period last year[22] - The net cash flow from investing activities improved by ¥9,582,741.67 or 36.21%, totaling -¥16,880,941.47 in Q1 2015[22] - Total assets at the end of the reporting period were CNY 2,087,616,093.75, down 6.17% from CNY 2,224,830,183.70 at the end of the previous year[8] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 29,994[11] - CIMIC Industrial Inc. held 49.62% of shares, with 216,823,488 shares pledged[11] - The company did not engage in any repurchase transactions during the reporting period[12] Operational Changes - The company has fully relocated its production line from Shanghai to Jiangxi, and the Shanghai subsidiary has ceased operations[28] - The company has committed to providing financial support to its subsidiary to assist in resolving short-term debt difficulties[28] - There are no significant changes expected in the company's production and operational conditions, indicating stability in performance[29] Future Plans - The company plans to establish two wholly-owned subsidiaries with a registered capital of ¥100 million each, focusing on health care and elderly care investments[24] - A new wholly-owned subsidiary, Shanghai Smick Investment Co., Ltd., will be established with a registered capital of ¥500 million for equity investment and management[24] - The company aims to enhance its core competitiveness and profitability through investments and acquisitions in the health and elderly care sectors[24] Other Financial Metrics - The weighted average return on equity was -2.71%, an improvement of 0.77% compared to -3.48% in the previous year[8] - Prepayments increased by 165.73% to CNY 34,225,150.94 from CNY 12,879,539.18 at the end of the previous year[16] - Other receivables decreased by 76.97% to CNY 23,384,512.91 from CNY 101,530,099.93 year-on-year[16] - The company reported a decrease in income tax expenses, with no tax recorded for the current period compared to ¥103,764.17 in the same period last year[20] - The company does not hold any securities investments during the reporting period[30] - The company has not held shares in other listed companies during the reporting period[31]